| Literature DB >> 34067550 |
Yoshihisa Fujinami1, Toru Hifumi2, Yuko Ono1, Masafumi Saito1, Tomoya Okazaki2, Natsuyo Shinohara2, Kyoko Akiyama2, Misa Kunikata2, Shigeaki Inoue1, Joji Kotani1, Yasuhiro Kuroda2.
Abstract
A single-center retrospective cohort study examined the association between molar malocclusion status at ICU admission and loss of activities of daily living (ADL) at hospital discharge among acutely ill patients. Patients were assigned to the bilateral occlusion group or malocclusion group (N = 227 and 93, respectively). The following data were collected from electronic medical records: age, sex, Clinical Frailty Scale (CFS) on admission, Acute Physiology and Chronic Health Evaluation (APACHE) Ⅱ score, confirmed diagnosis (neurological disorders or others), CFS at hospital discharge, and occlusion condition. Patients who were frail at admission (CFS > 5) were excluded from analysis, and ADL loss was defined as CFS > 5 at hospital discharge. Multivariate analysis showed malocclusion was independently associated with ADL loss [OR, 2.03; 95% CI, 1.13-3.64; p = 0.02]. For those aged 65 and older, malocclusion was significantly associated with both ADL loss [OR, 3.25; 95% CI, 1.44-7.32; p < 0.01] and the incidence of delirium [OR, 2.61; 95% CI, 1.14-5.95; p = 0.02]. Malocclusion on ICU admission was associated with ADL loss in critically ill patients, and was associated with ADL loss and the incidence of delirium in the elderly. Poor oral health was a poor prognostic factor among critically ill patients.Entities:
Keywords: ICU prognosis; frailty; poor oral health
Year: 2021 PMID: 34067550 PMCID: PMC8156973 DOI: 10.3390/jcm10102157
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Study participants’ enrolment flow chart.
Baseline characteristics of the study population.
| Variables | Total | Bilateral Occlusion | Malocclusion | |
|---|---|---|---|---|
| N | 320 | 227 | 93 | |
| Age (years) | 69 (57–79) | 62 (48–74) | 69 (64–77) | <0.01 * |
| Sex (male) (%) | 179 (56) | 128 (57) | 51 (54) | 0.62 # |
| CFS on admission (%) | <0.01 ## | |||
| Scale 1 | 21 (7) | 19 (8) | 2 (2) | |
| Scale 2 | 101 (32) | 83 (37) | 19 (20) | |
| Scale 3 | 113 (35) | 75 (33) | 38 (41) | |
| Scale 4 | 57 (18) | 32 (14) | 25 (27) | |
| Scale 5 | 27 (8) | 18 (8) | 9 (10) | |
| APACHE II score | 15 (11–21) | 13 (10–18) | 17 (13–24) | <0.01 * |
| Neurological disorders (%) | 128 (40) | 87 (39) | 41 (43) | 0.46 # |
| Death in Hospital (%) | 16 (5) | 9 (4) | 7 (7) | 0.35 # |
| ADL loss (%) | 93 (29) | 50 (22) | 44 (46) | <0.01 # |
| VFDs (mean ± SD, median) | 21.2 ± 9.6, 27 | 22.6 ± 8.4, 27 | 18.1 ± 11.2, 24 | 0.50 * |
| N | 290 | 209 | 81 | |
| Delirium (%) | 68 (23) | 39 (19) | 29 (36) | <0.01 # |
CFS, Clinical Frailty Scale; APACHE, Acute Physiology and Chronic Health Evaluation; ADL, Activities of Daily Living; VFDs, Ventilator-Free Days; SD, standard deviation. *: The Mann-Whitney U test was used. #: The Fisher exact test was used. ##: Chi-squared test was used. Data are presented as number (percentage), or median (interquartile range).
Baseline characteristics of the study population 65 years and older.
| Variables | Total | Bilateral Occlusion | Malocclusion | |
|---|---|---|---|---|
| N | 171 | 103 | 68 | |
| Age (years) | 75 (69–82) | 76 (69–82) | 74.5 (69–79) | 0.20 * |
| Sex (male) (%) | 83 (49) | 50 (49) | 33 (49) | 1.00 # |
| CFS on admission (%) | <0.01 ## | |||
| Scale 1 | 0 | 0 | 0 | |
| Scale 2 | 29 (17) | 22 (21) | 7 (10) | |
| Scale 3 | 73 (43) | 41 (40) | 32 (47) | |
| Scale 4 | 45 (26) | 24 (23) | 21 (31) | |
| Scale 5 | 24 (14) | 16 (16) | 8 (12) | |
| APACHE II score | 16 (13–22) | 15 (12–19) | 19 (13–24) | <0.01 * |
| Neurological disorders (%) | 74 (43) | 49 (48) | 25 (37) | 0.16 # |
| Death in Hospital (%) | 10 (6) | 4 (4) | 4 (6) | 0.42 # |
| ADL loss (%) | 58 (34) | 26 (25) | 32 (47) | <0.01 # |
| N | 153 | 93 | 60 | |
| Delirium (%) | 49 (32) | 29 (31) | 20 (33) | 0.30 # |
CFS, Clinical Frailty Scale; APACHE, Acute Physiology and Chronic Health Evaluation; ADL, Activities of Daily Living; SD, standard deviation. *: The Mann-Whitney U test was used. #: The Fisher exact test was used. ##: Chi-squared test was used. Data are presented as number (percentage), or median (interquartile range).
Univariate and multivariate analyses for ADL loss of the study population.
| Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|
| Variables | Crude OR | 95% CI | Adjusted OR | 95% CI | ||
| Age | 1.03 | 1.00–1.04 | <0.01 | 1.00 | 0.98–1.02 | 0.94 |
| Sex (male) | 1.03 | 0.63–1.67 | 0.89 | 1.30 | 0.74–2.31 | 0.35 |
| CFS on admission | 2.19 | 1.48–5.77 | <0.01 | 1.94 | 1.40–2.71 | <0.01 |
| APACHE II score | 1.12 | 1.04–2.71 | <0.01 | 1.09 | 1.05–1.14 | <0.01 |
| Neurological disorders | 2.03 | 1.24–3.30 | <0.01 | 2.55 | 1.44–4.57 | <0.01 |
| Malocclusion | 3.02 | 1.81–5.03 | <0.01 | 2.03 | 1.13–3.64 | 0.02 |
CFS, Clinical Frailty Scale; APACHE, Acute Physiology and Chronic Health Evaluation; ADL, Activities of Daily Living; OR, odds ratio; CI, confidence interval; reference = bilateral occlusion.
Univariate and multivariate analyses for ADL loss of the study population 65 years and older.
| Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|
| Variables | Crude OR | 95% CI | Adjusted OR | 95% CI | ||
| Age | 1.09 | 1.04–1.14 | <0.01 | 1.08 | 1.02–1.15 | <0.01 |
| Sex (male) | 0.89 | 0.47–1.67 | 0.71 | 1.11 | 0.51–2.40 | 0.80 |
| CFS on admission | 2.37 | 1.60–3.50 | <0.01 | 2.20 | 1.38–3.49 | <0.01 |
| APACHE II score | 1.09 | 1.03–1.14 | <0.01 | 1.06 | 1.00–1.12 | 0.04 |
| Neurological disorders | 1.87 | 0.99–3.55 | 0.06 | 2.86 | 1.32–6.23 | <0.01 |
| Malocclusion | 2.63 | 1.37–5.05 | <0.01 | 3.25 | 1.44–7.32 | <0.01 |
CFS, Clinical Frailty Scale; APACHE, Acute Physiology and Chronic Health Evaluation; ADL, Activities of Daily Living; OR, odds ratio; CI, confidence interval; reference = bilateral occlusion.
Univariate and Multivariate analysis for Delirium of the study population.
| Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|
| Variables | Crude OR | 95% CI | Adjusted OR | 95% CI | ||
| Age | 1.03 | 1.01–1.05 | <0.01 | 1.01 | 0.99–1.03 | 0.37 |
| Sex (male) | 0.89 | 0.56–1.43 | 0.64 | 1.04 | 0.61–1.76 | 0.88 |
| CFS on admission | 1.78 | 1.39–2.26 | <0.01 | 1.40 | 1.05–1.95 | 0.02 |
| APACHE II score | 1.11 | 1.07–1.15 | <0.01 | 1.09 | 1.05–1.13 | <0.01 |
| Neurological disorders | 1.82 | 1.13–2.94 | <0.01 | 1.97 | 1.16–3.36 | 0.01 |
| Malocclusion | 2.14 | 1.29–3.53 | <0.01 | 1.33 | 0.76–2.34 | 0.32 |
CFS, Clinical Frailty Scale; APACHE, Acute Physiology and Chronic Health Evaluation; ADL, Activities of Daily Living; OR, odds ratio; CI, confidence interval; reference = bilateral occlusion.
Univariate and Multivariate analysis for Delirium of the study population 65 years and older.
| Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|
| Variables | Crude OR | 95% CI | Adjusted OR | 95% CI | ||
| Age | 1.10 | 1.05–1.16 | <0.01 | 1.13 | 1.06–1.20 | <0.01 |
| Sex (male) | 0.89 | 0.48–1.67 | 0.72 | 1.18 | 0.55–2.54 | 0.68 |
| CFS on admission | 1.32 | 0.94–1.87 | 0.11 | 1.01 | 0.65–1.58 | 0.97 |
| APACHE II score | 1.06 | 1.01–1.10 | 0.01 | 1.07 | 1.01–1.13 | 0.02 |
| Neurological disorders | 4.03 | 2.07–7.84 | <0.01 | 5.82 | 2.63–12.90 | <0.01 |
| Malocclusion | 1.92 | 1.01–3.64 | 0.05 | 2.61 | 1.14–5.95 | 0.02 |
CFS, Clinical Frailty Scale; APACHE, Acute Physiology and Chronic Health Evaluation; ADL, Activities of Daily Living; OR, odds ratio; CI, confidence interval; reference = bilateral occlusion.
Figure 2Correlation diagram of Aging, Frailty, and Oral Frailty.
Clinical Frailty Scale.
Subgroup analysis by stratifying the level of CFS at admission to observe the difference of CFS in each level of ADL.
| Bilateral | Malocclusion | ||||||
|---|---|---|---|---|---|---|---|
| CFS |
| CFS | Event |
| CFS | Event | |
| 1 | 0.34 | ||||||
| 21 | 1 (0) | 0 | 2 | 1 (0) | 0 | ||
| 2 (1) | 7 (33) | 2 (1) | 0 | ||||
| 3 (2) | 8 (38) | 3 (2) | 1 (50) | ||||
| 4 (3) | 3 (14) | 4 (3) | 0 | ||||
| 5 (4) | 1 (5) | 5 (4) | 1 (50) | ||||
| 6–9 (5–8) | 2 (10) | 6–9 (5–8) | 0 | ||||
| 2 | 0.09 | ||||||
| 83 | 2 (0) | 16 (19) | 19 | 2 (0) | 1 (5) | ||
| 3 (1) | 34 (41) | 3 (1) | 4 (21) | ||||
| 4 (2) | 14 (17) | 4 (2) | 6 (32) | ||||
| 5 (3) | 8 (10) | 5 (3) | 4 (21) | ||||
| 6–9 (4–7) | 11 (13) | 6–9 (4–6) | 4 (21) | ||||
| 3 | 0.02 | ||||||
| 75 | 3 (0) | 23 (31) | 38 | 3 (0) | 3 (8) | ||
| 4 (1) | 22 (29) | 4 (1) | 11 (29) | ||||
| 5 (2) | 14 (19) | 5 (2) | 8 (21) | ||||
| 6–9 (3–6) | 16 (21) | 6–9 (3–5) | 16 (42) | ||||
| 4 | 0.14 | ||||||
| 32 | 4 (0) | 11 (34) | 25 | 4 (0) | 7 (25) | ||
| 5 (1) | 8 (25) | 5 (1) | 2 (8) | ||||
| 6–9 (2–5) | 13 (41) | 6–9 (2–4) | 16 (64) | ||||
| 5 | 0.20 | ||||||
| 18 | 5 (0) | 7 (39) | 9 | 5 (0) | 1 (11) | ||
| 6–9 (1–4) | 11 (61) | 6–9 (1–3) | 8 (89) | ||||
CFS, Clinical Frailty Scale. p values were calculated by the Fisher exact test.
The quantifications of the interaction between the variables of the multivariate analysis.
| ADL loss | |
| Age*Mal | <0.01 |
| Sex (male)*Mal | 0.07 |
| APACHE*Mal | <0.01 |
| Neuro*Mal | 0.45 |
| Delirium | |
| Age*Mal | <0.01 |
| Sex (male)*Mal | 0.438 |
| APACHE*Mal | <0.01 |
| Neuro*Mal | 0.11 |
CFS, Clinical Frailty Scale; APACHE, Acute Physiology and Chronic Health Evaluation; ADL, Activities of Daily Living; Mal, Malocclusion.